.: "targeted cgrp small molecule antagonists for acute migraine therapy."...

in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance..

..

.

"the hospital � i don't know what to say. everyone was amazing," he said. https://drbryanpwalsh.com/Merriweather-grandma-of-Huffstutter-from-Grafton?Barilfath=148

it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done..turn on desktop notifications for breaking stories about interest?.